A Study to Evaluate the Safety & Efficacy of TS-091 in Patients With

See also
Status	Clinical Trial	Phase
Completed	`NCT04072380` - A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy	Phase 2
Withdrawn	`NCT03626727` - Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia	Early Phase 1
Completed	`NCT02821715` - Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients	Phase 2
Completed	`NCT01789398` - Patient Narcoleptic Treated With BF2.649 (Pitolisant) in add-on to Sodium Oxybate (HARMONY IV)	Phase 3
Completed	`NCT01681121` - A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy	Phase 2
Completed	`NCT00174174` - Provigil (Modafinil) Study by Taiwan Biotech Co.	N/A
Completed	`NCT05059223` - A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy	Phase 3
Completed	`NCT04923594` - Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of Narcolepsy	Phase 2
Recruiting	`NCT06279247` - Proteomics and Metabolomics of Body Fluid in Patients With Narcolepsy
Completed	`NCT04647903` - Study to Evaluate the Abuse Liability, Pharmacokinetics, Safety and Tolerability of an Abuse-Deterrent d-Amphetamine Sulfate Immediate Release Formulation (ADAIR)	Phase 1
Completed	`NCT03173378` - Evaluation of Academic and Professional Trajectories of Narcoleptic Patients
Completed	`NCT05055024` - An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy	Phase 2
Completed	`NCT01067235` - Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy	Phase 3
Completed	`NCT00228566` - Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome	Phase 3
Completed	`NCT00107796` - Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy	Phase 3
Completed	`NCT00132873` - Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy	Phase 3
Completed	`NCT00107848` - PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome	Phase 3
Enrolling by invitation	`NCT05113745` - A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy	Phase 3
Suspended	`NCT04419792` - 'A Profile of Physical Performance Variables in an Out-patient Adult Population With Narcolepsy'
Recruiting	`NCT04899947` - Child and Adolescent Registry for Participants With Narcolepsy

NCT number	NCT03267303
Study type	Interventional
Source	Taisho Pharmaceutical Co., Ltd.
Contact
Status	Completed
Phase	Phase 2
Start date	October 31, 2017
Completion date	August 8, 2019

A Study to Evaluate the Safety and Efficacy of TS-091 in Patients With Narcolepsy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms